406 related articles for article (PubMed ID: 19280552)
21. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
22. Contrast-enhanced sonography with abdominal virtual sonography in monitoring radiofrequency ablation of hepatocellular carcinoma.
Kisaka Y; Hirooka M; Koizumi Y; Abe M; Matsuura B; Hiasa Y; Onji M
J Clin Ultrasound; 2010; 38(3):138-44. PubMed ID: 20014137
[TBL] [Abstract][Full Text] [Related]
23. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
[TBL] [Abstract][Full Text] [Related]
24. Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone.
Lekht I; Gulati M; Nayyar M; Katz MD; Ter-Oganesyan R; Marx M; Cen SY; Grant E
Abdom Radiol (NY); 2016 Aug; 41(8):1511-21. PubMed ID: 26969495
[TBL] [Abstract][Full Text] [Related]
25. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures.
Cedrone A; Pompili M; Sallustio G; Lorenzelli GP; Gasbarrini G; Rapaccini GL
Am J Gastroenterol; 2001 Jun; 96(6):1854-9. PubMed ID: 11419839
[TBL] [Abstract][Full Text] [Related]
26. Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection.
Wang Y; Liao J; Qi W; Xie L; Li Y
Ultrasound Med Biol; 2016 May; 42(5):1042-8. PubMed ID: 26803390
[TBL] [Abstract][Full Text] [Related]
27. Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.
Gao Y; Zheng DY; Cui Z; Ma Y; Liu YZ; Zhang W
World J Gastroenterol; 2015 Sep; 21(36):10418-26. PubMed ID: 26420968
[TBL] [Abstract][Full Text] [Related]
28. Sono-hepatic-arteriography (Sono-HA) in the assessment of hepatocellular carcinoma in patients undergoing transcatheter arterial chemoembolization (TACE).
Schacherer D; Girlich C; Zorger N; Wiest R; Schoelmerich J; Feuerbach S; Jung EM
Ultraschall Med; 2010 Jun; 31(3):270-5. PubMed ID: 20408118
[TBL] [Abstract][Full Text] [Related]
29. Contrast-enhanced ultrasound-guided radiofrequency ablation in inconspicuous hepatocellular carcinoma on B-mode ultrasound.
Kim EJ; Kim YS; Shin SK; Kwon OS; Choi DJ; Kim JH
Turk J Gastroenterol; 2017 Nov; 28(6):446-452. PubMed ID: 29086712
[TBL] [Abstract][Full Text] [Related]
30. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
[TBL] [Abstract][Full Text] [Related]
31. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
[TBL] [Abstract][Full Text] [Related]
32. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome.
Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C
AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673
[TBL] [Abstract][Full Text] [Related]
33. Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound.
Dong Y; Wang WP; Mao F; Ji ZB; Huang BJ
J Gastroenterol Hepatol; 2016 Apr; 31(4):822-8. PubMed ID: 26480287
[TBL] [Abstract][Full Text] [Related]
34. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma.
Giorgio A; Tarantino L; de Stefano G; Scala V; Liorre G; Scarano F; Perrotta A; Farella N; Aloisio V; Mariniello N; Coppola C; Francica G; Ferraioli G
AJR Am J Roentgenol; 2003 Aug; 181(2):479-84. PubMed ID: 12876030
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients.
Li K; Su Z; Xu E; Huang Q; Zeng Q; Zheng R
BMC Cancer; 2017 Jan; 17(1):61. PubMed ID: 28103837
[TBL] [Abstract][Full Text] [Related]
37. Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound.
Bartolotta TV; Taibbi A; Midiri M; De Maria M
Abdom Imaging; 2008; 33(5):501-11. PubMed ID: 17786507
[TBL] [Abstract][Full Text] [Related]
38. Local ablation procedures in primary liver tumors: Levovist US versus spiral CTto evaluate therapeutic results.
Vallone P; Gallipoli A; Izzo F; Fiore F; Delrio P
Anticancer Res; 2003; 23(6D):5075-9. PubMed ID: 14981969
[TBL] [Abstract][Full Text] [Related]
39. Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience.
Minami Y; Kudo M; Hatanaka K; Kitai S; Inoue T; Hagiwara S; Chung H; Ueshima K
Liver Int; 2010 May; 30(5):759-64. PubMed ID: 20456042
[TBL] [Abstract][Full Text] [Related]
40. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
